CAI Stock Summary and Trading Ideas (Caris Life Sciences | NASDAQ:CAI)

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Caris Life Sciences trades on the NASDAQ stock market under the symbol CAI.

As of July 15, 2026, CAI stock price climbed to $17.46 with 6,177,386 million shares trading.

CAI has a beta of 1.74, meaning it tends to be more sensitive to market movements. CAI has a correlation of 0.14 to the broad based SPY ETF.

CAI has a market cap of $4.94 billion. This is considered a Mid Cap stock.

Last quarter Caris Life Sciences reported $216 million in Revenue and $.00 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.02.

The top ETF exchange traded funds that CAI belongs to (by Net Assets): VTI, VB, VBK, IBB, IWP.

CAI has underperformed the market in the last year with a price return of -37.0% while the SPY ETF gained +22.0%. CAI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -13.5% and -2.0%, respectively, while the SPY returned +9.0% and +1.1%, respectively.

CAI support price is $16.25 and resistance is $17.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CAI shares will trade within this expected range on the day.